Top Core and Group Health Stories
Pharma profits come under fire in House hearing
By Michael McAuliffAn investigation from the House Oversight Committee pins the blame for high drug costs on Big Pharma's quest for profits.
News, insight, and analysis from industry experts to help benefits brokers, consultants and advisors make their way through the tumultuous reformed health care marketplace. Content will help them grow their practices by focusing on a wide range of products, discussing new sales and marketing strategies and highlighting innovative and disruptive brokers who are forging a new path in today's benefits marketplace.
An investigation from the House Oversight Committee pins the blame for high drug costs on Big Pharma's quest for profits.